BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29346733)

  • 21. Rational design of highly potent broad-spectrum enterovirus inhibitors targeting the nonstructural protein 2C.
    Bauer L; Manganaro R; Zonsics B; Hurdiss DL; Zwaagstra M; Donselaar T; Welter NGE; van Kleef RGDM; Lopez ML; Bevilacqua F; Raman T; Ferla S; Bassetto M; Neyts J; Strating JRPM; Westerink RHS; Brancale A; van Kuppeveld FJM
    PLoS Biol; 2020 Nov; 18(11):e3000904. PubMed ID: 33156822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyrazolopyridines with potent activity against herpesviruses: effects of C5 substituents on antiviral activity.
    Gudmundsson KS; Johns BA; Allen SH
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1157-61. PubMed ID: 18086523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and anti-enterovirus activity of new analogues of MDL-860.
    Dobrikov GM; Slavchev I; Nikolova I; Stoyanova A; Nikolova N; Mukova L; Nikolova R; Shivachev B; Galabov AS
    Bioorg Med Chem Lett; 2017 Oct; 27(19):4540-4543. PubMed ID: 28870395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, structure-activity relationship and in vitro biological evaluation of N-arylethyl isoquinoline derivatives as Coxsackievirus B3 inhibitors.
    Wang YX; Li YH; Li YH; Gao RM; Wang HQ; Liu YX; Gao LM; Lu QN; Jiang JD; Song DQ
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5787-90. PubMed ID: 21880491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of new 3,4,5-trisubstituted isothiazoles as effective inhibitory agents of enteroviruses.
    Cutrì CC; Garozzo A; Siracusa MA; Sarvà MC; Castro A; Geremia E; Pinizzotto MR; Guerrera F
    Bioorg Med Chem; 1999 Feb; 7(2):225-30. PubMed ID: 10218813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and antiviral activity of a new series of 4-isothiazolecarbonitriles.
    Cutrí CC; Garozzo A; Siracusa MA; Sarvá MC; Tempera G; Geremia E; Pinizzotto MR; Guerrera F
    Bioorg Med Chem; 1998 Dec; 6(12):2271-80. PubMed ID: 9925289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor TTP-8307.
    De Palma AM; Thibaut HJ; van der Linden L; Lanke K; Heggermont W; Ireland S; Andrews R; Arimilli M; Al-Tel TH; De Clercq E; van Kuppeveld F; Neyts J
    Antimicrob Agents Chemother; 2009 May; 53(5):1850-7. PubMed ID: 19237651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral Effects of Novel 2-Benzoxyl-Phenylpyridine Derivatives.
    Wei Y; Wang H; Xi C; Li N; Li D; Yao C; Sun G; Ge H; Hu K; Zhang Q
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32204528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel pleconaril derivatives: Influence of substituents in the isoxazole and phenyl rings on the antiviral activity against enteroviruses.
    Egorova A; Kazakova E; Jahn B; Ekins S; Makarov V; Schmidtke M
    Eur J Med Chem; 2020 Feb; 188():112007. PubMed ID: 31881489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of broad-spectrum enterovirus antivirals based on quinoline scaffold.
    Musharrafieh R; Kitamura N; Hu Y; Wang J
    Bioorg Chem; 2020 Aug; 101():103981. PubMed ID: 32559580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of dibucaine derivatives as novel potent enterovirus 2C helicase inhibitors: In vitro, in vivo, and combination therapy study.
    Tang Q; Xu Z; Jin M; Shu T; Chen Y; Feng L; Zhang Q; Lan K; Wu S; Zhou HB
    Eur J Med Chem; 2020 Sep; 202():112310. PubMed ID: 32619885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and Structure-Activity Relationships of Diarylhydrazides as Novel Potent and Selective Human Enterovirus Inhibitors.
    Han X; Sun N; Wu H; Guo D; Tien P; Dong C; Wu S; Zhou HB
    J Med Chem; 2016 Mar; 59(5):2139-50. PubMed ID: 26885567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiviral activity of benzimidazole derivatives. III. Novel anti-CVB-5, anti-RSV and anti-Sb-1 agents.
    Tonelli M; Novelli F; Tasso B; Vazzana I; Sparatore A; Boido V; Sparatore F; La Colla P; Sanna G; Giliberti G; Busonera B; Farci P; Ibba C; Loddo R
    Bioorg Med Chem; 2014 Sep; 22(17):4893-909. PubMed ID: 25082514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uncovering oxysterol-binding protein (OSBP) as a target of the anti-enteroviral compound TTP-8307.
    Albulescu L; Bigay J; Biswas B; Weber-Boyvat M; Dorobantu CM; Delang L; van der Schaar HM; Jung YS; Neyts J; Olkkonen VM; van Kuppeveld FJM; Strating JRPM
    Antiviral Res; 2017 Apr; 140():37-44. PubMed ID: 28088354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of pyrazolo[4',3':5,6]pyrano[2,3-d]pyrimidine derivatives for antiviral evaluation.
    Shamroukh AH; Zaki ME; Morsy EM; Abdel-Motti FM; Abdel-Megeid FM
    Arch Pharm (Weinheim); 2007 May; 340(5):236-43. PubMed ID: 17464958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Vitro Antiviral Activity of New Oxazoline Derivatives as Potent Poliovirus Inhibitors.
    Madia VN; Messore A; Pescatori L; Saccoliti F; Tudino V; De Leo A; Scipione L; Fiore L; Rhoden E; Manetti F; Oberste MS; Di Santo R; Costi R
    J Med Chem; 2019 Jan; 62(2):798-810. PubMed ID: 30512950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification, design and synthesis of novel pyrazolopyridine influenza virus nonstructural protein 1 antagonists.
    Patnaik S; Basu D; Southall N; Dehdashti S; Wan KK; Zheng W; Ferrer M; Taylor M; Engel DA; Marugan JJ
    Bioorg Med Chem Lett; 2019 May; 29(9):1113-1119. PubMed ID: 30852083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2-Amino-3-substituted-6-[(E)-1-phenyl-2-(N-methylcarbamoyl)vinyl]imid azo[1,2-a]pyridines as a novel class of inhibitors of human rhinovirus: stereospecific synthesis and antiviral activity.
    Hamdouchi C; de Blas J; del Prado M; Gruber J; Heinz BA; Vance L
    J Med Chem; 1999 Jan; 42(1):50-9. PubMed ID: 9888832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Progress in Research on Structure, Function and Antiviral of Enterovirus A71 3C Protein].
    Li J; Wen H; Wang Z
    Bing Du Xue Bao; 2015 Jul; 31(4):468-73. PubMed ID: 26524922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis & structure-activity relationships of a new class of antihuman enterovirus D68 & A71 agents.
    Sethy B; Hsieh CF; Yeh C; Horng JT; Hsieh PW
    Future Med Chem; 2018 Jun; 10(11):1333-1347. PubMed ID: 29745776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.